Summary
Myocardial viability did not predict a survival benefit from surgical revascularization among patients with ischemic heart disease and left ventricular dysfunction, according to the findings of a substudy of the Surgical Treatment for Ischemic Heart Failure Trial [STICH].
- Interventional Techniques & Devices
- Heart Failure Clinical Trials
- © 2011 MD Conference Express
Tools
Table of contents
Cited By...
- No citing articles found.